| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $275.2B | $254.5B | $242.3B | $227.0B | $195.9B | $166.8B | $141.6B | $42.3B |
| Cost of Revenue | $239.9B | $222.4B | $212.6B | $199.4B | $170.7B | $46.4B | $38.7B | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $25.0B | $22.8B | $21.6B | $19.8B | $18.5B | $5.0B | $4.3B | $4.1B |
| Operating Income | $10.4B | $9.3B | $8.1B | $7.8B | $6.7B | $1.9B | $1.4B | $1.4B |
| Net Income | $8.1B | $7.4B | $6.3B | $5.8B | $5.0B | $1.4B | $1.0B | $0.9B |
| EPS (Basic) | $18.24 | $16.59 | $14.18 | $13.17 | $11.30 | $3.14 | $2.38 | $2.10 |
| EPS (Diluted) | $18.21 | $16.56 | $14.16 | $13.14 | $11.27 | $3.13 | $2.36 | $2.08 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $77.1B | $69.8B | $69.0B | $64.2B | $59.3B | $55.6B | $40.8B | $36.3B |
| Current Assets | $38.4B | $34.2B | $35.9B | $32.7B | $29.5B | $28.1B | $20.3B | $17.3B |
| Cash & Equivalents | $14.2B | $9.9B | $13.7B | $10.2B | $11.3B | $12.3B | $6.1B | $4.5B |
| Total Liabilities | $47.9B | $46.2B | $43.9B | $43.5B | $41.2B | $36.9B | $27.7B | $25.3B |
| Current Liabilities | $37.1B | $35.5B | $33.6B | $32.0B | $29.4B | $24.8B | $19.9B | $17.5B |
| Stockholders' Equity | $29.2B | $23.6B | $25.1B | $20.6B | $17.6B | $18.3B | $12.8B | $10.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $13.3B | $11.3B | $11.1B | $7.4B | $9.0B | $8.9B | — | — |
| Investing Cash Flow | $-5.3B | $-4.4B | $-5.0B | $-3.9B | $-3.5B | $-3.9B | — | — |
| Capital Expenditures | $5.5B | $4.7B | $4.3B | $3.9B | $3.6B | $2.8B | $3.0B | $2.5B |
| Financing Cash Flow | $-3.8B | $-10.8B | $-2.6B | $-4.3B | $-6.5B | $-1.1B | — | — |